Literature DB >> 12039881

Patient compliance with antibiotic treatment for respiratory tract infections.

Przemyslaw Kardas1.   

Abstract

Despite doctors' expectations, non-compliance is common in short-term antibiotic therapy of respiratory tract infections (RTIs). This phenomenon has profound practical implications. It leads to ineffective management, the deterioration of patients' health, hospital admissions, additional costs and the emergence of antibiotic-resistant microorganisms. This article reviews methods of measuring compliance with antibiotics in the outpatient-based management of RTIs and research results. Causes of non-compliance are also discussed. Factors influencing compliance are analysed, as well as practical strategies for addressing non-compliance with antibiotic therapies for RTIs. The influence of the frequency of doses on compliance is particularly stressed, as it has been observed that once daily dosing has almost a 100% compliance rate. As a number of once-daily antibiotic preparations are available now, the possibility of using once-daily schedules for improving compliance in RTI cases is stressed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039881     DOI: 10.1093/jac/dkf046

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  45 in total

Review 1.  [Sense and nonsense in antibiotic therapy for respiratory tract infections].

Authors:  W Domej; E Flögel; G P Tilz; U Demel
Journal:  Internist (Berl)       Date:  2005-07       Impact factor: 0.743

2.  Assessment of antibiotic prescribing at different hospitals and primary health care facilities.

Authors:  Salih Mollahaliloglu; Ali Alkan; Basak Donertas; Senay Ozgulcu; Ahmet Akici
Journal:  Saudi Pharm J       Date:  2012-11-10       Impact factor: 4.330

3.  Relationship between Adherence to Oral Antibiotics and Postdischarge Clinical Outcomes among Patients Hospitalized with Staphylococcus aureus Skin Infections.

Authors:  Samantha J Eells; Megan Nguyen; Jina Jung; Raul Macias-Gil; Larissa May; Loren G Miller
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 4.  Strategies to combat antimicrobial resistance.

Authors:  Rajesh R Uchil; Gurdeep Singh Kohli; Vijay M Katekhaye; Onkar C Swami
Journal:  J Clin Diagn Res       Date:  2014-07-20

5.  A study assessing public knowledge, belief and behavior of antibiotic use in an omani population.

Authors:  Jimmy Jose; Beena Jimmy; Al Gahliya Mohammed Saif Alsabahi; Ghalya Abdullah Al Sabei
Journal:  Oman Med J       Date:  2013-09

6.  A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis.

Authors:  Mark Abelson; Eugene Protzko; Aron Shapiro; Ana Garces-Soldana; Lyle Bowman
Journal:  Clin Ophthalmol       Date:  2007-06

7.  Perceived Quality of Care of Community Health Worker and Facility-Based Health Worker Management of Pneumonia in Children Under 5 Years in Western Kenya: A Cross-Sectional Multidimensional Study.

Authors:  Brian I Shaw; Elijah Asadhi; Kevin Owuor; Peter Okoth; Mohammed Abdi; Craig R Cohen; Maricianah Onono
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

8.  A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.

Authors:  Julian G Hurdle; Robin B Lee; Nageshwar R Budha; Elizabeth I Carson; Jianjun Qi; Michael S Scherman; Sang Hyun Cho; Michael R McNeil; Anne J Lenaerts; Scott G Franzblau; Bernd Meibohm; Richard E Lee
Journal:  J Antimicrob Chemother       Date:  2008-08-07       Impact factor: 5.790

9.  Topical retapamulin in the management of infected traumatic skin lesions.

Authors:  Ribhi Shawar; Nicole Scangarella-Oman; Marybeth Dalessandro; John Breton; Monique Twynholm; Gang Li; Harmony Garges
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

10.  Problem drug use the public health imperative: what some of the literature says.

Authors:  Gez Bevan
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.